Evaluation of BPPV with vertebral artery values.

abstract：Purpose:Paliperidone extended release (ER) is an oral psychotropic treatment formulated to release paliperidone at a controlled, gradually ascending rate. We evaluated the efficacy and safety of switching to paliperidone ER in Taiwanese patients with schizophrenia who were unresponsive or intolerant to previous antipsy...

journal_title：Neuropsychiatric disease and treatment

authors： Chen CY,Tang TC,Chen TT,Bai YM,Tsai HH,Chen HL,Huang CJ,Chen CK,Chen CC,Hsiao MC,Liu CY,Yeh HS,Chiu NY,Hsiao CC,Chen CS,Su TP

更新日期：2018-03-08 00:00:00

abstract：BACKGROUND:The size and increasing burden of disease due to mental disorders in Europe poses substantial challenges to its population and to the health policy of the European Union. This warrants a specific research agenda concerning clinical mental health research as one of the cornerstones of sustainable mental healt...

journal_title：Neuropsychiatric disease and treatment

authors： van der Feltz-Cornelis CM,van Os J,Knappe S,Schumann G,Vieta E,Wittchen HU,Lewis SW,Elfeddali I,Wahlbeck K,Linszen D,Obradors-Tarragó C,Haro JM

更新日期：2014-06-27 00:00:00

abstract：BACKGROUND:Depressive symptoms are significant and very common psychiatric complications in patients with Alzheimer's disease (AD), which can aggravate the decline in social function. However, changes in the functional connectivity (FC) of the brain in AD patients with depressive symptoms (D-AD) remain unclear. OBJECT...

journal_title：Neuropsychiatric disease and treatment

authors： Zhang J,Guo Z,Liu X,Jia X,Li J,Li Y,Lv D,Chen W

更新日期：2017-10-11 00:00:00

abstract：:Co-morbid depression is common in patients with diabetes mellitus and has a negative impact on diabetes self-care, adherence to treatment and the development of complications. Effective treatment of depression has been associated with improvement in metabolic parameters. We evaluated the feasibility of a two question ...

journal_title：Neuropsychiatric disease and treatment

authors： Abrahamian H,Hofmann P,Prager R,Toplak H

更新日期：2009-01-01 00:00:00

abstract：:The pharmacodynamic properties of fluvoxamine maleate include the modulation of different populations of serotonergic, dopaminergic, and sigma receptors and/or transporters, a complex pattern of activity that may account for its efficacy in the treatment of obsessive-compulsive disorder (OCD). Nevertheless, its pharma...

journal_title：Neuropsychiatric disease and treatment

authors： Ordacgi L,Mendlowicz MV,Fontenelle LF

更新日期：2009-01-01 00:00:00

abstract：:Dystonia is a rare manifestation of multiple sclerosis (MS), but it always interferes with the functional performance and quality of life. We report a rare case of long-lasting paroxysmal dystonia associated with MS. The patient was a 40-year-old woman with relapsing- remitting MS for 6 years. During the latest attack...

journal_title：Neuropsychiatric disease and treatment

authors： Hsieh PC,Chen SM,Guo YH,Kuan TS,Yen WJ,Chang WC,Lin YC

更新日期：2013-01-01 00:00:00

abstract：BACKGROUND:Anterior cingulate cortex (ACC) dysfunction is implicated in schizophrenia by numerous strands of scientific investigation. Functional neuroimaging studies of the ACC in schizophrenia have shown task-related hypo-activation, hyper-activation, and normal activation relative to comparison subjects. Interpretin...

journal_title：Neuropsychiatric disease and treatment

authors： Adams R,David AS

更新日期：2007-02-01 00:00:00

abstract：:An 87-year-old woman had both Lewy body dementia and normal pressure hydrocephalus simultaneously. One should not automatically exclude the possibility of normal pressure hydrocephalus simply because another neurodegenerative disorder is present, especially if the second disorder masks typical symptoms of normal press...

journal_title：Neuropsychiatric disease and treatment

authors： Alisky J

更新日期：2008-02-01 00:00:00

abstract：:This study evaluates the correlation between failure to develop spontaneous imitation and language skills in pervasive developmental disorders. Sixty-four children between the age of 3 and 8 years were assessed using the Autism Diagnostic Interview-Revised (ADI-R), the Childhood Autism Rating Scale (CARS), and the Aut...

journal_title：Neuropsychiatric disease and treatment

authors： De Giacomo A,Portoghese C,Martinelli D,Fanizza I,L'abate L,Margari L

更新日期：2009-01-01 00:00:00

abstract：:Anxiety is currently one of the main mood changes and can impair the quality of life of the individual when associated with other neurological or psychiatric disorders. Neuromodulation has been highlighted as a form of treatment of several pathologies, including those involving anxiety symptoms. Among the neuromodulat...

journal_title：Neuropsychiatric disease and treatment

authors： Rodrigues PA,Zaninotto AL,Neville IS,Hayashi CY,Brunoni AR,Teixeira MJ,Paiva WS

更新日期：2019-09-23 00:00:00

abstract：:The relapse rate for many psychiatric disorders is staggeringly high, indicating that treatment methods combining psychotherapy with neuropharmacological interventions are not entirely effective. Therefore, in psychiatry, there is a current push to develop alternatives to psychotherapy and medication-based approaches....

journal_title：Neuropsychiatric disease and treatment

authors： Campanella S

更新日期：2013-01-01 00:00:00

abstract：:[This retracts the article DOI: 10.2147/NDT.S214595.]. ...

journal_title：Neuropsychiatric disease and treatment

authors：

更新日期：2019-08-22 00:00:00

abstract：BACKGROUND:PULSE was a large, observational, multicenter study designed to evaluate the efficacy and safety of agomelatine in the treatment of major depression in patients with cardiovascular disease (CVD). METHODS:Patients with mild-to-moderate major depressive episodes, without psychotic symptoms, were treated as ou...

journal_title：Neuropsychiatric disease and treatment

authors： Medvedev VE

更新日期：2017-04-21 00:00:00

abstract：Background:Schizophrenia is a debilitating psychiatric disorder characterized by molecular and anatomical abnormalities of multiple brain regions. Our recent study showed that dysbiosis of the gut microbiota contributes to the onset of schizophrenia-relevant behaviors, but the underlying mechanisms remain largely unkno...

journal_title：Neuropsychiatric disease and treatment

authors： Liang W,Huang Y,Tan X,Wu J,Duan J,Zhang H,Yin B,Li Y,Zheng P,Wei H,Xie P

更新日期：2019-11-19 00:00:00

abstract：BACKGROUND:Following the approval of lisdexamfetamine dimesylate (LDX) in several European countries for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children and adolescents with an inadequate response to methylphenidate (MPH) treatment, the aim of the present analysis was to establish the respo...

journal_title：Neuropsychiatric disease and treatment

authors： Coghill DR,Banaschewski T,Lecendreux M,Soutullo C,Zuddas A,Adeyi B,Sorooshian S

更新日期：2014-10-29 00:00:00

abstract：OBJECTIVE:This study provides insight into the thoughts and opinions of geriatric health-care professionals toward cognitive assessments and the use of emerging technologies, such as eye-tracking, to supplement current tools. METHODS:Two focus group sessions were conducted with nurses and physicians who routinely admi...

journal_title：Neuropsychiatric disease and treatment

authors： Whitehead JC,Gambino SA,Richter JD,Ryan JD

更新日期：2015-06-12 00:00:00

abstract：Purpose:This study examined the links between 24-hour activity patterns (specifically, amplitude and timing of wrist activity) and the persisting qualities of clinical antidepressant response to the glutamatergic modulator ketamine. Methods:Twenty-four-hour activity patterns were compared across 5 days of 24-hour acti...

journal_title：Neuropsychiatric disease and treatment

authors： Duncan WC Jr,Slonena EE,Hejazi NS,Brutsche N,Park LT,Henter ID,Ballard ED,Zarate CA Jr

更新日期：2018-10-16 00:00:00

abstract：:It has been well established that patients with schizophrenia have impairments in cognitive functioning and also that patients who experienced traumatic events suffer from cognitive deficits. Of the cognitive deficits revealed in schizophrenia or posttraumatic stress disorder (PTSD) patients, the current article provi...

journal_title：Neuropsychiatric disease and treatment

authors： Jung W,Lee SH

更新日期：2016-05-10 00:00:00

abstract：PURPOSE:The aim of this study was to ascertain the clinical characteristics of drug-induced sleep-related eating disorder (SRED). PATIENTS AND METHODS:We retrospectively reviewed the medical records of 30 patients with primary SRED (without any comorbid sleep disorders and who were not taking any possible causative me...

journal_title：Neuropsychiatric disease and treatment

authors： Komada Y,Takaesu Y,Matsui K,Nakamura M,Nishida S,Kanno M,Usui A,Inoue Y

更新日期：2016-05-26 00:00:00

abstract：BACKGROUND:Patients with schizophrenia show disturbances in both visual perception and social cognition. Perception of biological motion (BM) is a higher-level visual process, and is known to be associated with social cognition. BM induces activation in the "social brain network", including the superior temporal sulcus...

journal_title：Neuropsychiatric disease and treatment

authors： Hashimoto N,Toyomaki A,Hirai M,Miyamoto T,Narita H,Okubo R,Kusumi I

更新日期：2014-11-17 00:00:00

abstract：:Dopaminergic agents, anticonvulsants, benzodiazepines, opiates, and iron supplementation comprise the classes of medications commonly used to treat restless legs syndrome (RLS), which is a disorder that is estimated to affect about 1 in 10 individuals worldwide and impacts an affected patient's sleep, mood, daytime fu...

journal_title：Neuropsychiatric disease and treatment

authors： Kushida CA

更新日期：2006-12-01 00:00:00

abstract：Background:It is known that miR-532-5p is critical for neuronal differentiation. However, the role of miR-532-5p in depression remains unknown. This study aimed to investigate the role and mechanism of miR-532-5p in major depressive disorder (MDD). Methods:The depression mice model was established by chronic unpredict...

journal_title：Neuropsychiatric disease and treatment

authors： Yan X,Zeng D,Zhu H,Zhang Y,Shi Y,Wu Y,Tang H,Li D

更新日期：2020-11-12 00:00:00

abstract：Purpose:Dual diagnosis (DD) is the co-occurrence of both a mental illness and a substance use disorder (SUD). Lots of studies have analysed the integrated clinical approach, which involves both psychiatry and toxicology medical experts. The purpose of this study is to analyse the socio-demographic characteristics and t...

journal_title：Neuropsychiatric disease and treatment

authors： Milano G,Vergani HM,Cattedra S,Carrozzino R,Mattioli F,Robbiano L,Martelli A

更新日期：2019-12-18 00:00:00

abstract：:Psychiatric and physical conditions often coexist, and there is robust evidence that associates the frequency of depression with single and multiple physical conditions. More than half of patients with depression may have at least one chronic physical condition. Therefore, antidepressants are often used in cotherapy w...

journal_title：Neuropsychiatric disease and treatment

authors： Low Y,Setia S,Lima G

更新日期：2018-02-19 00:00:00

abstract：:Headaches in children and adolescents are still under-diagnosed. 75% of children are affected by primary headache by the age of 15 with 28% fitting the ICHD2 criteria of migraine. Migraine is considered a chronic disorder that can severely impact a child's daily activities, including schooling and socializing. Early r...

journal_title：Neuropsychiatric disease and treatment

authors： Kabbouche MA,Gilman DK

更新日期：2008-06-01 00:00:00

abstract：OBJECTIVE:Insomnia can be broadly defined as difficulty initiating or maintaining sleep, or sleep that is not refreshing or of poor quality with negative effect on daytime function. Insomnia can be a primary condition or comorbid to an underlying disorder. Subjective measures of insomnia used in population studies, usu...

journal_title：Neuropsychiatric disease and treatment

authors： Wade AG

更新日期：2010-12-20 00:00:00

abstract：BACKGROUND:No study has examined the financial impact of relapses on schizophrenia from the perspective of Japanese society. This study aimed to estimate the societal costs in Japan caused by the relapses of schizophrenia. METHODS:The societal costs in Japan in 2013 due to relapses of schizophrenia were estimated by s...

journal_title：Neuropsychiatric disease and treatment

authors： Nakamura Y,Mahlich J

更新日期：2017-05-17 00:00:00

abstract：Purpose:Ginkgo biloba extract (GBE) contains diterpene ginkgolides (DGs), which have been shown to have neuroprotective effects by a number of previous studies. We previously demonstrated part of the action of DG. However, the impact of DG on the prefrontal cortex (PFC) remains unclear. Here, we evaluated the effects o...

journal_title：Neuropsychiatric disease and treatment

authors： Hu Q,Shen P,Bai S,Dong M,Liang Z,Chen Z,Wang W,Wang H,Gui S,Li P,Xie P

更新日期：2018-04-13 00:00:00

abstract：:In Diagnostic and Statistical Manual of Mental Disorders, fifth edition, psychogenic non-epileptic seizures (PNES) do not have a unique classification as they can be found within different categories: conversion, dissociative, and somatization disorders. The ICD-10, instead, considers PNES within dissociative disorder...

journal_title：Neuropsychiatric disease and treatment

authors： Beghi M,Negrini PB,Perin C,Peroni F,Magaudda A,Cerri C,Cornaggia CM

更新日期：2015-09-30 00:00:00

abstract：:Pregabalin is a new antiepileptic medication that works by binding to alpha 2 delta subunit of the voltage-dependent calcium channels present in presynaptic neurons. Its pharmacokinetic advantages include rapid and almost complete absorption, lack of protein binding, linear kinetics, absence of enzyme induction, and a...

journal_title：Neuropsychiatric disease and treatment

authors： Arain AM

更新日期：2009-01-01 00:00:00